These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8516833)
1. Failure of azathioprine and steroids to augment one-day-pretransplant donor-specific transfusion-enhanced allograft survival. Madden RL; Brunson ME; Alexander JW; Davies CB Transplantation; 1993 Jun; 55(6):1436-8. PubMed ID: 8516833 [No Abstract] [Full Text] [Related]
2. Comparison of the effect of a 5-mg/kg and 10-mg/kg cyclosporine loading dose with single and multiple donor-specific transfusions on rat cardiac allograft survival. Fisher RA; Cohen DS; Alexander JW; Davies CB; Schroeder TJ Transplant Proc; 1994 Oct; 26(5):3056-9. PubMed ID: 7940961 [No Abstract] [Full Text] [Related]
3. Effect of ultraviolet-B-irradiated donor-specific blood transfusion and cyclosporine on cardiac allograft survival and mixed lymphocyte reaction in rats. Koh YB; Park IY; Lee YK Transplant Proc; 1994 Aug; 26(4):1952-3. PubMed ID: 8066632 [No Abstract] [Full Text] [Related]
4. A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine. Gyopar AF; Loertscher R; Guttman RD; Tchervenkov JI Transplantation; 1993 May; 55(5):1199-202. PubMed ID: 8497904 [No Abstract] [Full Text] [Related]
5. Donor-specific transfusion and cyclosporine prolong allograft survival when given in the peroperative period. Cofer BR; Tchervenkov JI; Alexander JW; Barnwell SC Transplant Proc; 1991 Feb; 23(1 Pt 1):157-8. PubMed ID: 1990501 [No Abstract] [Full Text] [Related]
6. Is donor-specific blood transfusion effective for strong minor histocompatibility antigen barriers? Hara MH; Suzuki H; Shibata K; Tanigawa M; Sekiya R; Matsuzaki Y; Onitsuka T; Koga Y; Yamashita A; Miyamoto M; Suzuki S; Amemiya H; Kimura H Transplant Proc; 1996 Jun; 28(3):1268-9. PubMed ID: 8658654 [No Abstract] [Full Text] [Related]
7. Female sex hormone, estradiol, antagonizes the immunosuppressive activity of cyclosporine in rat organ transplantation. Hirasawa K; Kamada N Transplant Proc; 1992 Feb; 24(1):408-9. PubMed ID: 1311480 [No Abstract] [Full Text] [Related]
8. Comparison of kidney, composite tissue, and skin allograft survival in rats prolonged by donor blood and concomitant limited cyclosporine. Hewitt CW; Black KS; Stenger JA; Go C; Achauer BM; Martin DC Transplant Proc; 1988 Jun; 20(3 Suppl 3):1110-3. PubMed ID: 3291221 [No Abstract] [Full Text] [Related]
9. Induction of long-term rat cardiac allograft survival in rats with multiple donor specific transfusions and cyclosporine. Perez RV; Heyd TJ; Munda R; Babcock G; Alexander JW Curr Surg; 1988; 45(1):9-12. PubMed ID: 3278865 [No Abstract] [Full Text] [Related]
10. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats. Lin Y; Goebels J; Vandeputte M; Waer M Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485 [No Abstract] [Full Text] [Related]
11. Prolactin suppression enhances the effects of perioperative donor-specific blood transfusions on graft survival. Martinelli GP; Liu H; Clarke WP; Heisenleder DJ; Knight RJ J Surg Res; 1996 Aug; 64(2):190-7. PubMed ID: 8812632 [TBL] [Abstract][Full Text] [Related]
12. Donor specific transfusions: a five-year experience with alternative protocols. Norman DJ; Henell K; Fletcher L; Barry J Transplant Proc; 1987 Feb; 19(1 Pt 3):2252-4. PubMed ID: 3274504 [No Abstract] [Full Text] [Related]
14. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers. Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184 [TBL] [Abstract][Full Text] [Related]
15. Effect of blood transfusion and cyclophosphamide on cardiac allograft survival in sensitized mice. Lasek W; Sora M; Jakóbisiak M Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):399-403. PubMed ID: 8572899 [TBL] [Abstract][Full Text] [Related]
16. Examination of the clonal deletion hypothesis following transfusions in rat cardiac transplants. Takiff H; Novak M; Yin L; Iwaki Y; Terasaki PI Transplant Proc; 1987 Feb; 19(1 Pt 2):1452-4. PubMed ID: 3274352 [No Abstract] [Full Text] [Related]
17. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy. Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761 [TBL] [Abstract][Full Text] [Related]
18. Failure of donor irradiation and graft lymph node reduction to prolong pancreas allograft survival in cyclosporine- and donor-specific transfusion-treated hosts. Schulak JA; Cooke JC; Herrmann MJ Transplantation; 1990 Aug; 50(2):341-3. PubMed ID: 2382302 [No Abstract] [Full Text] [Related]
19. The role of blood transfusion in the age of cyclosporine. Perloff LJ Transplant Proc; 1986 Apr; 18(2 Suppl 1):29-37. PubMed ID: 3515691 [No Abstract] [Full Text] [Related]
20. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study. Opelz G Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]